Melissa Severn

Canadian Agency for Drugs and Technologies in Health

Papers

Total Citations

H-Index

About

Melissa Severn is a leading health technology assessment (HTA) researcher whose work has fundamentally shaped the evidence base for robotic surgery adoption. Her primary research areas encompass comparative effectiveness research, health economics, and systematic review methodology, with a particular focus on surgical innovation. Severn's landmark 2011 Health Technology Assessment, "Robot-Assisted Surgery Compared with Open Surgery and Laparoscopic Surgery: Clinical Effectiveness and Economic Analyses," stands as her most influential contribution, amassing 75 citations. This comprehensive systematic review critically evaluated whether the substantial costs of robotic platforms translate into meaningful clinical benefits over conventional laparoscopic and open approaches. Her 2012 follow-up work narrowed the focus to four procedures of high priority to Canadian health systems—prostatectomy, hysterectomy, nephrectomy, and cardiac surgery—providing decision-makers with actionable evidence on where robotic surgery offers genuine value. Through rigorous synthesis of clinical outcomes and cost-effectiveness data, Severn has helped temper over-enthusiastic adoption of expensive surgical technologies, ensuring that healthcare resources are directed toward interventions with proven patient benefit. Her work remains essential reading for health policy researchers, surgeons, and hospital administrators navigating the complex trade-offs of surgical innovation.